wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38154679-03549641-F0A3-40FB-B8C0-3238CD599333
Q38154679-03549641-F0A3-40FB-B8C0-3238CD599333
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38154679-03549641-F0A3-40FB-B8C0-3238CD599333
Composite endpoints in trials of type-2 diabetes.
P2860
Q38154679-03549641-F0A3-40FB-B8C0-3238CD599333
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38154679-03549641-F0A3-40FB-B8C0-3238CD599333
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b029871fbb0b2f479262f6929b60c6880515c9d
P2860
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.